Cancer discovery
The most recent articles from:
Cancer Discov
-
In a phase II trial, the tyrosine kinase inhibitor sunitinib was effective in previously treated patients with thymic carcinoma, offering the first viable second-line treatment option for patients with this rare and aggressive form of thymus cancer.
-
Randomized Controlled Trial
Pictilisib stalls advanced ER+/PR+ breast cancer.
-
The experimental drug AG-120, which inhibits mutant IDH1, showed promising results in a phase I trial in patients with relapsed or refractory acute myeloid leukemia.